Early Phase 1 Parkinson's Disease Trial, Recruiting (NCT05893186)

Early Phase 1 Parkinson's Disease Trial, Recruiting NCT05893186 Sponsor: University of Minnesota Condition: Parkinson's Disease

Printed from Voxsanity (voxsanity.com.au) — NCT05893186 — Data sourced from ClinicalTrials.gov. Verify directly with the trial site before attending. Not medical advice.

Back to Parkinsons Disease

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

People who have been diagnosed with Parkinson's disease
People who have had deep brain stimulation (DBS) devices implanted on both sides of the brain
People whose DBS system uses a specific type of lead (electrode) that can direct stimulation in different directions
People who had a high-powered MRI scan (at least 7 Tesla) that included a specific type of brain imaging called diffusion tensor imaging, taken before their DBS surgery
People who had a CT scan of the head (with image slices of at least 1mm) taken after their DBS surgery
People whose DBS device was first switched on at least 3 months ago

Who may not be able to join:

People who have a neurological or musculoskeletal condition (other than Parkinson's) that significantly affects their walking, balance, or limb movements
People who have dementia
People who have previously had a type of brain surgery (called stereotactic neurosurgery) for a movement disorder, other than the DBS surgery already mentioned
People who are pregnant

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.

Last synced 27 July 2026

Early Phase 1 studies are small, early exploratory studies that come before the main Phase 1 to 3 testing, so a standard phase success rate does not apply.

Contact this trial

Principal Investigator: Scott Cooper, MD, PhD, University of Minnesota

Phone: 763-353-9470

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Voxsanity

Clinical trials and treatments, explained plainly · voxsanity.com.au

Date:

To: My Doctor

Re: Clinical trial enquiry

I am writing to enquire about the following clinical trial which may be relevant to my care:

Trial: NCT05893186

Sponsor: University of Minnesota

Phase: Early Phase 1

Status: Recruiting

Condition: Parkinson's Disease

Trial contact: 763-353-9470

More information: https://clinicaltrials.gov/study/NCT05893186

Eligibility summary (AI generated)

Written by an AI model from ClinicalTrials.gov eligibility criteria and checked on a sample basis. Please confirm against the original criteria.

Who might be able to join this trial:

People who have been diagnosed with Parkinson's disease
People who have had deep brain stimulation (DBS) devices implanted on both sides of the brain
People whose DBS system uses a specific type of lead (electrode) that can direct stimulation in different directions
People who had a high-powered MRI scan (at least 7 Tesla) that included a specific type of brain imaging called diffusion tensor imaging, taken before their DBS surgery
People who had a CT scan of the head (with image slices of at least 1mm) taken after their DBS surgery
People whose DBS device was first switched on at least 3 months ago

Who may not be able to join:

People who have a neurological or musculoskeletal condition (other than Parkinson's) that significantly affects their walking, balance, or limb movements
People who have dementia
People who have previously had a type of brain surgery (called stereotactic neurosurgery) for a movement disorder, other than the DBS surgery already mentioned
People who are pregnant

Important: Always verify eligibility with the trial site directly before applying.

Access in Australia: A treatment being studied in a clinical trial is generally not yet listed on the PBS. Where a medicine is not approved or not available through a trial, the TGA Special Access Scheme may allow a doctor to access unapproved therapeutic goods for individual patients. See voxsanity.com.au/sas-navigator/ for a plain English explainer.

This information was sourced from ClinicalTrials.gov via Voxsanity (data last synced 27 July 2026). It is not medical advice. Please verify the trial's current status directly with the trial site before acting.

Trial details

Status

Recruiting

Phase

Early Phase 1

Sponsor

University of Minnesota

Registry

ClinicalTrials.gov

Start date

25 May 2021

Est. completion

15 July 2029

Where this trial is recruiting

🇺🇸 United States

Primary endpoints

Gait test

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 27 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov